Skip to content

A clinical trial to evaluate the efficacy of Gokshura Brihatyadi Kashaya in the management of prameha Janya upadravas with special reference to Diabetic Nephropathy.

A Randomized controlled clinical trial to evaluate the efficacy of Gokshura Brihatyadi Kashaya in the management of prameha Janya upadravas with special reference to Diabetic Nephropathy.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051259
Enrollment
60
Registered
2023-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

None listed

Sponsors

DrViraj V Shukla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pre diagnosed patients of Type 2 DM will be included in study. 2. Patients of both sexes of the age in between 40-70 yrs will be included in study. 3. Patients with lab values a) Sr. Creatinine b) Microalbuminuria c) BUN 4. Patients of Diabetic Nephropathy up to reversible stage i.e. overt Diabetic Nephropathy. 5. Patients having symptoms as described in Ayurveda classical text as, a) Akshikuta Shotha b) Pada Shotha c) Sarvang Shotha d) Mutralpata e) Kshudhalpata f) Hrillas / Chhardi will be included in study.

Exclusion criteria

Exclusion criteria: 1. Type 1 DM will be excluded from study. 2. Patients of Type 2 DM on insulin will be excluded from study. 3. Patients having any other serious illnesses like Tuberculosis, HIV/AIDS, Congestive Cardiac Failures, Chronic Kidney Disease, Morbidly Obese will be excluded from study.

Design outcomes

Primary

MeasureTime frame
To asses whether microalbumin urea levels remains in normal range i.e.30 to 300 mg per 24 hrs At Baseline And after 8 weeks of trial drug intervention. Timepoint: Both subjective and Objective assesment will done at baseline and after 8 weeks.

Secondary

MeasureTime frame
To Study The Probable Mode Of Action Of Gokshura Brihatyadi kashaya In Diabetic Nephropathy. The Pharmacological Properties Of The Compound Drug Gokshura Brihatyadi kashaya will be Assessed as per Ayurveda principles like Rasa, Veerya, Vipak, Prabhav Through Literature In Context With Improvement In Subjective And Objective Parameters.Timepoint: Subjective and Objective Parameters Will Be Assessed At Baseline,And After 8 Weeks

Countries

India

Contacts

Public ContactDr viraj v shukla

Chhatrapati Shahu Maharaj Shikshan Sansthas Ayurved Mahavidyalaya And Rugnalaya.

dr.shrikantgdeshmukh@gmail.com9921553999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026